Federal budget woes continue to imperil cancer research: Patients also are affected by the loss of money available for trials

Cancer

Volumn 119, Issue 23, 2013, Pages 4055-4056

  Printz, Carrie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BUDGET; CANCER RESEARCH; COST OF ILLNESS; FUNDING; GOVERNMENT REGULATION; HEALTH CARE COST; HUMAN; INVESTMENT; MEDICAL RESEARCH; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT;

BUDGETS; CLINICAL TRIALS AS TOPIC; FINANCING, GOVERNMENT; HUMANS; NEOPLASMS; RESEARCH SUPPORT AS TOPIC; UNITED STATES;

EID: 84887969059     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28473     Document Type: Article

References (1)

1. Friedman T,. The way we were. New York Times. September 24, 2013. nytimes.com/2013/09/25/opinion/friedman-the-way-we-were.html. Accessed October 18, 2013.